Coming to a CVS near you: A store brand monoclonal antibody

CVS is getting into the business of making biosimilars to profit directly from blockbusters going generic.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...